All osteomiRs have been carefully selected based on a series of studies in the context of
The osteomiR microRNA signature is intended to assess the risk of a first fracture in female patients of postmenopausal osteoporosis and type-2 diabetes. This information enables timely interventions and can help to avoid fractures.
Every single microRNA can be used as individual bone-related biomarker with distinct information content.
Our new study presents the first comprehensive attempt to model the cost-effectiveness of circulating microRNAs for bone fracture risk assessment in a central European female post menopausal population in comparison to DXA and FRAX®. The results demonstrate that the osteomiR™ kit can help reduce fracture incidence and healthcare costs.
we test your sample with our osteomiRTM kit - more about this service